Reply

[1]  G. Ciprandi,et al.  The clinical relevance of the clinical cytological grading in patients with chronic rhinosinusitis with nasal polyps , 2020, Journal of Allergy and Clinical Immunology.

[2]  R. Lockey,et al.  Rhinitis Phenotypes. , 2020, The journal of allergy and clinical immunology. In practice.

[3]  J. Mullol,et al.  The sense of smell in chronic rhinosinusitis. , 2020, The Journal of allergy and clinical immunology.

[4]  W. Fokkens.  EPOS2020: a major step forward. , 2020, Rhinology.

[5]  I Alobid,et al.  European Position Paper on Rhinosinusitis and Nasal Polyps 2020. , 2020, Rhinology.

[6]  C. Bachert,et al.  Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials , 2019, The Lancet.

[7]  V. Quaranta,et al.  Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity , 2019, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[8]  J. Bousquet,et al.  EUFOREA consensus on biologics for CRSwNP with or without asthma , 2019, Allergy.

[9]  R. Panettieri,et al.  Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size , 2018, The Laryngoscope.

[10]  N. Quaranta,et al.  Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach , 2017, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[11]  T. Morikawa,et al.  Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study , 2015, Allergy.

[12]  G. Ciprandi,et al.  Role of nasal cytology. , 2010, International journal of immunopathology and pharmacology.